ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,475, issued on March 3, was assigned to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Suwon-si, South Korea).
"Small molecule compound inhibiting signal transmission path of TLR7 and TLR9 and use thereof" was invented by Sangdun Choi (Suwon-si, South Korea), Haseeb Muhammad (Suwon-si, South Korea), Mahesh Patra (Suwon-si, South Korea) and Yang-Seon Choi (Suwon-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of Chemical Formula 1 or a pharmaceutically acceptable salt thereof is disclosed. The compound inhibits a toll-like receptor (TLR) signaling pathway. A composition containing the compound and uses thereof are...